Your trusted source for investing success

Tag: EU

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!

Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results

Iovance Biotherapeutics (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today reported its fourth quarter and year-end 2017 financial results and provided a corporate update.

As quoted in the press release:
“We ended 2017 having completed significant accomplishments involving both manufacturing and clinical aspects of development

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Progress

Atara Biotherapeutics (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today reported financial results for the fourth quarter and full year ended December 31, 2017 and recent operational highlights.

As quoted in the press release:
“Atara continues to advance its leadership in

Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by a Subsidiary of Roivant Sciences

Avid Bioservices (NASDAQ:CDMO) a company working to improve patient lives by providing high quality biologics manufacturing services to biotechnology and pharmaceutical companies, today announced that Enzyvant, a subsidiary of Roivant Sciences, has selected Avid as the commercial drug substance manufacturer for RVT-801, its recombinant human acid ceramidase enzyme replacement therapy being

Siemens and Partners Sign Joint Charter on Cybersecurity

Siemens (NQB:SIEGY) and eight partners announced at the Munich Cybersecurity Conference that they will sign the first joint charter for greater cybersecurity.

As quoted in the press release:
Initiated by Siemens, the Charter of Trust calls for binding rules and standards to build trust in cybersecurity and further advance digitalization. In addition

Santhera Obtains Worldwide Exclusive License from Polyphor to Develop and Commercialize Clinical Stage Candidate for Cystic Fibrosis

Santhera Pharmaceuticals (SIX: SANN) announces that it has entered into a license agreement with Polyphor Ltd. for POL6014, a clinical stage selective inhibitor of human neutrophil elastase with the potential to treat cystic fibrosis (CF) and other neutrophilic pulmonary diseases such as non-cystic fibrosis bronchiectasis (NCFB), alpha-1 antitrypsin deficiency (AATD)

Synthesis Energy Systems, TAURON Wytwarzanie, and SES EnCoal Energy Announce Feasibility Study for First Conventional Power Boiler Clean Energy Conversion Projects in Poland

Synthesis Energy Systems (NASDAQ:SES) has announced that it and TAURON Wytwarzanie S.A., and SES’s Poland platform company SES Encoal Energy have executed a letter of intent to develop Poland’s first SES Gasification Technology (SGT) facility.

As quoted in the press release:

TAURON has contracted Poland’s Institute of Coal Chemistry (IChPW) to complete a

10 Top 3D Printing Companies

10 Top 3D Printing Companies

It’s expected that the 3D Printing market will be worth over $30 billion by 2022. Here, the Investing News Network looks at 10 of the big players in the industry.

Novo Nordisk Ozempic approved in the EU for the treatment of type 2 diabetes

Novo Nordisk (CPH:NOVO-B) announced that the European Commission (EC) has granted marketing authorisation for Ozempic® (semaglutide) for the treatment of adults with type 2 diabetes. Ozempic® is a new once-weekly analogue of human glucagon-like peptide-1 (GLP-1) indicated as monotherapy when metformin is considered inappropriate due to intolerance or is contraindicated, and as

10+ Gold Stocks to Watch

Expert Insights.
Industry Stats.

Give me my free report!
Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
Cannabis Weekly Round-Up: US Operator Launches on the CSE